8-K: Clene Inc. Announces 1-for-20 Reverse Stock Split to Regain Nasdaq Compliance

Clene Inc. has announced a 1-for-20 reverse stock split effective July 11, 2024, to regain compliance with Nasdaq's minimum bid price requirement.

Summary

• Clene Inc. has implemented a 1-for-20 reverse stock split of its common stock.
• The reverse stock split will be effective at 12:01 a.m. Eastern Time on July 11, 2024.
• The company's common stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on July 11, 2024, under a new CUSIP number.
• The primary reason for the reverse stock split is to regain compliance with the $1.00 minimum closing bid price required for continued listing on the Nasdaq Capital Market.
• The reverse stock split will reduce the number of outstanding shares from approximately 128.7 million to approximately 6.4 million.
• Fractional shares will not be issued; instead, stockholders will receive cash based on the closing price of the common stock on July 10, 2024.
• All outstanding stock options, warrants, and other securities convertible into common stock will be adjusted accordingly.
• The total number of authorized shares of common and preferred stock will not be reduced, and the par values will remain unchanged.

Sentiment

Score: 5

Explanation: The document is neutral in tone, focusing on the mechanics of the reverse stock split. While necessary for compliance, it doesn't indicate positive or negative sentiment about the company's future prospects.

Positives

• The reverse stock split is a strategic move to regain compliance with Nasdaq listing requirements.
• The company is taking proactive steps to maintain its listing on the Nasdaq Capital Market.
• The reverse stock split will not affect the ownership percentage of existing stockholders, except for fractional shares.
• The company has engaged Equiniti Trust Company, LLC, as the exchange agent to facilitate the process.

Negatives

• The reverse stock split is a consequence of the company's stock price falling below the Nasdaq minimum bid price.
• The reverse stock split may be perceived negatively by some investors as it reduces the number of outstanding shares.
• Stockholders will receive cash in lieu of fractional shares, which may not be ideal for all investors.

Risks

• The company's ability to maintain compliance with Nasdaq's continued listing standards is not guaranteed.
• General market conditions could impact the effectiveness of the reverse stock split.
• The company's future performance may be materially different from forward-looking statements due to various risks and uncertainties.
• There is a risk that the reverse stock split may not achieve the desired effect of increasing the stock price.

Future Outlook

The company aims to regain compliance with Nasdaq's minimum bid price requirement through the reverse stock split, but there are no guarantees of success and the company is subject to general market conditions and other risks.

Management Comments

• The Board of Directors approved the 1-for-20 reverse stock split ratio.
• Management believes the reverse stock split is necessary to maintain the company's listing on the Nasdaq Capital Market.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from major exchanges due to low stock prices. This action is often seen in the biotechnology sector, where companies may experience volatility due to the nature of their research and development activities.

Comparison to Industry Standards

• Reverse stock splits are a common mechanism used by companies to regain compliance with exchange listing requirements, particularly when a stock price falls below the minimum threshold.
• Other companies in the biotechnology sector, such as Athersys and Ocugen, have also implemented reverse stock splits to maintain their Nasdaq listings.
• The 1-for-20 ratio is within the range of reverse stock splits seen in the industry, which can vary from 1-for-2 to 1-for-50 or more.
• The success of a reverse stock split in increasing the stock price and maintaining listing compliance varies, and is dependent on the company's underlying performance and market conditions.

Stakeholder Impact

• Shareholders will experience a reduction in the number of shares they own, but their ownership percentage will remain the same, except for fractional shares.
• Shareholders will receive cash in lieu of fractional shares.
• The reverse stock split is intended to benefit shareholders by maintaining the company's listing on the Nasdaq Capital Market.

Next Steps

• The reverse stock split will be effective on July 11, 2024.
• The company's common stock will begin trading on a split-adjusted basis on July 11, 2024.
• Equiniti will provide instructions to stockholders regarding the exchange of pre-split stock certificates.

Key Dates

Keywords

reverse stock split, Nasdaq compliance, common stock, stock options, warrants, CUSIP number, fractional shares, listing requirements, Clene Inc., shareholders